SOURCE: IBC Life Sciences

August 31, 2005 15:00 ET

IBC's 4th Molecular Diagnostics and Personalized Medicine Conference

Scientific, Business and Regulatory Strategies for Companion Diagnostic Products and Individualized Therapeutics

WESTBOROUGH, MA -- (MARKET WIRE) -- August 31, 2005 -- Now in its 4th year, IBC's Molecular Diagnostics and Personalized Medicine conference brings a unique two-track meeting that addresses all sides of the science and business behind a diagnostics market that is expected to grow at more then 15% annually in the coming decade.

This comprehensive two-track meeting includes the Business, Regulatory and Reimbursement Strategies Track, which has been produced in partnership with Boston Healthcare, and the Science and Technology Track, which will cover both Molecular Diagnostics Technologies and Personalized Medicine.

This is the industry's only conference that addresses the full spectrum of viewpoints from all the major stakeholders in the molecular diagnostics field:

--  Pharmaceutical
--  Biotech
--  Diagnostics
--  Payers
--  US FDA
--  Tech Platform Providers
--  Intellectual Property
    
Keynote addresses from:
--  Dr. Brian Spear, Director, Genomic and Proteomic Technologies, Abbott
    Laboratories
--  Dr. Klaus Lindpaintner, Vice President, Hoffman-La Roche
    
Plus, this year the Molecular Diagnostics and Personalized Medicine conference is conveniently co-located with IBC's Chips to Hits® -- the world's premier microarray event. Both events will be taking place on September 12-15, 2005, in Boston at the Boston Convention & Exhibition Center (BCEC).

For additional up-to-date event information on the Molecular Diagnostics and Personalized Medicine Conference visit: www.IBCLifeSciences.com/diagnostics.

To receive a press pass for this event or to arrange an interview with a speaker, email Dawn Eagan at deagan@ibcusa.com.

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: www.IBCLifeSciences.com.

Contact Information